To verify this in vitro data, we analyzed the effects of Kindlin-2 on pancreatic cancer progression using a xenograft model by implanting human wild-type or Kindlin-2 knockdown MIA PaCa-2 cells into mice. The gene discussed is FERMT2; the disease is pancreatic neoplasm.